A Randomized Withdrawal Double-blind Study of Etanercept Monotherapy Compared to Methotrexate Monotherapy for Maintenance of Remission in Subjects With Rheumatoid Arthritis
Phase of Trial: Phase III
Latest Information Update: 10 Oct 2017
At a glance
- Drugs Etanercept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Amgen
- 10 Jun 2017 Biomarkers information updated
- 21 Mar 2017 Planned number of patients changed from 720 to 465.
- 21 Mar 2017 Planned End Date changed from 1 Nov 2019 to 18 May 2020.